Systemic lupus erythematosus.
D000293:Adolescent; D000974:Antibodies, Antinuclear / Q000276:immunology; D000962:Antimalarials / Q000627:therapeutic use; D001168:Arthritis / Q000175:diagnosis; D002648:Child; D003176:Complement C3 / Q000032:analysis; D003181:Complement C4 / Q000032:analysis; D004247:DNA / Q000276:immunology; D005260:Female; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000175:diagnosis* / Q000276:immunology / Q000628:therapy; D008297:Male; D009504:Neutrophils; D011241:Prednisone / Q000627:therapeutic use; D011379:Prognosis; D012871:Skin Diseases / Q000175:diagnosis
D000974:Antibodies, Antinuclear; D000962:Antimalarials; D003176:Complement C3; D003181:Complement C4; D004247:DNA; D011241:Prednisone